Article Sidebar

Submitted
July 25, 2025
Accepted
July 25, 2025
Published
June 30, 2025
Download
pdf
Statistic
Read Counter : 537 Download : 285

Main Article Content

Abstract

Background: The association between serum adiponectin levels and acute
myocardial infarction, particularly how adiponectin predicts the development of
acute myocardial infarction in patients, remains unresolved. Hence, we aimed to
determine whether higher adiponectin levels predict cardiovascular events and
mortality in these patients.
Methods: At Al-Nasiriyah Heart Hospital, 60 patients diagnosed with acute
myocardial infarction (AMI) and 60 healthy controls participated in a case
control study. ELISA was used to measure serum ADIPOQ levels, and
fluorescent immunoassay was used to measure Hs-TnI levels. Serum creatinine,
blood urea, estimated glomerular filtration rate (eGFR), and fasting blood
glucose were also measured.
Results: When comparing AMI patients with the control group, the mean body
mass index (BMI), glomerular filtration rate, urea, creatinine, and Hs-TnI levels
were significantly higher. On the other hand, adiponectin levels and estimated
glomerular filtration rate were considerably lower in patients who had
experienced an acute myocardial infarction.
Conclusion: Patients with MI have significantly lower serum AdipoQ levels,
which are linked to elevated cardiac injury markers (Hs-TnI) and compromised
renal function.

Keywords

Adiponectin Acute Myocardial Infraction Renal Dysfunction

Article Details

License

Copyright (c) 2025 Akram Hassan Kadhum, Baida Rihan Ali

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

  1. Rajendran K, Devarajan N, Ganesan M, Ragunathan M. Obesity, Inflammation and Acute
  2. Myocardial Infarction - Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based
  3. population. Thromb J. 2012;10(1):13.
  4. Ibrahim AE, El-Yassin HD, Al-Janabi HK. The impact of inflammation on Resistin, Insulin and
  5. Troponin I in Acute Myocardial Infarction patients. Journal of the Faculty of Medicine Baghdad.
  6. ;53(3):338-42.
  7. Farhan S, Redfors B, Maehara A, McAndrew T, Ben-Yehuda O, De Bruyne B, et al. Relationship
  8. between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary
  9. syndromes: an analysis from the PROSPECT study. Cardiovasc Diabetol. 2021;20(1):10.
  10. Ekmen N, Helvaci A, Gunaldi M, Sasani H, Yildirmak ST. Leptin as an important link between
  11. obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart
  12. Journal. 2016;68(2):132-7.
  13. Chi GC, Kanter MH, Li BH, Qian L, Reading SR, Harrison TN, et al. Trends in Acute
  14. Myocardial Infarction by Race and Ethnicity. Journal of the American Heart Association.
  15. ;9(5):e013542.
  16. Dimitrova IN. Acute Myocardial Infarction in Young Individuals: Demographic and Risk Factor
  17. Profile, Clinical Features, Angiographic Findings and In-Hospital Outcome. Cureus.
  18. ;15(9):e45803.
  19. Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, et al.
  20. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC
  21. Cardiovasc Disord. 2023;23(1):206.
  22. Chen P, Zhang M, Zhang Y, Su X, Chen J, Xu B, et al. Economic Burden of Myocardial
  23. Infarction Combined With Dyslipidemia. Front Public Health. 2021;9:648172.
  24. Peng J, Chen Q, Wu C. The role of adiponectin in cardiovascular disease. Cardiovascular
  25. Pathology. 2023;64:107514.
  26. Zhao S, Kusminski CM, Scherer PE. Adiponectin, Leptin and Cardiovascular Disorders. Circ
  27. Res. 2021;128(1):136-49.
  28. Begum M, Choubey M, Tirumalasetty MB, Arbee S, Mohib MM, Wahiduzzaman M, et al.
  29. Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications. Life
  30. (Basel). 2023;13(11).
  31. Lei X, Qiu S, Yang G, Wu Q. Adiponectin and metabolic cardiovascular diseases: Therapeutic
  32. opportunities and challenges. Genes & Diseases. 2023;10(4):1525-36.
  33. da Silva Rosa SC, Liu M, Sweeney G. Adiponectin Synthesis, Secretion and Extravasation from
  34. Circulation to Interstitial Space. Physiology (Bethesda). 2021;36(3):134-49.
  35. Fang H, Judd RL. Adiponectin Regulation and Function. Compr Physiol. 2018;8(3):1031-63.
  36. Shemirani H, Sadeghi M, Dehkordi AD, Gheshlaghi F. Is high sensitive-troponin I a reliable
  37. biomarker for cardiac injury in methadone toxicity? A prospective cross-sectional study. BMC
  38. Pharmacology and Toxicology. 2022;23(1):17.
  39. Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS, et al. High-Sensitivity
  40. Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the
  41. Evaluation and Diagnosis of Acute Chest Pain. Circulation. 2022;146(7):569-81.
  42. Farmakis D, Richter D, Chronopoulou G, Goumas G, Kountouras D, Mastorakou A, et al. High
  43. sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals. Hellenic Journal of Cardiology. 2024;75:74-81.
  44. Al-Shaar L, Li Y, Rimm EB, Manson JE, Rosner B, Hu FB, et al. Body mass index and mortality
  45. among adults with incident myocardial infarction. American journal of epidemiology.
  46. ;190(10):2019-28.
  47. Borgeraas H, Hertel JK, Svingen GFT, Seifert R, Pedersen EKR, Schartum-Hansen H, et al.
  48. Association of body mass index with risk of acute myocardial infarction and mortality in
  49. Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort
  50. study. BMC cardiovascular disorders. 2014;14:1-10.
  51. Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al.
  52. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint
  53. position paper by the World Heart Federation and World Obesity Federation. European Journal of Preventive Cardiology. 2022;29(17):2218-37.
  54. Ritsinger V, Hagström E, Lagerqvist B, Norhammar A. Admission Glucose Levels and
  55. Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.
  56. Journal of the American Heart Association. 2021;10(22):e022667.
  57. Yufera-Sanchez A, Lopez-Ayala P, Nestelberger T, Wildi K, Boeddinghaus J, Koechlin L, et al.
  58. Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction. Scientific Reports. 2023;13(1):14598.
  59. Wang J, Yue X, Meng C, Wang Z, Jin X, Cui X, et al. Acute Hyperglycemia May Induce Renal
  60. Tubular Injury Through Mitophagy Inhibition. Frontiers in Endocrinology. 2020;Volume 11 - 2020.
  61. Cosentino N, Ballarotto M, Campodonico J, Milazzo V, Bonomi A, Genovesi S, et al. Impact of
  62. Glomerular Filtration Rate on the Incidence and Prognosis of New-Onset Atrial Fibrillation in Acute Myocardial Infarction. J Clin Med. 2020;9(5).
  63. Maksimczuk J, Galas A, Krzesiński P. What Promotes Acute Kidney Injury in Patients with
  64. Myocardial Infarction and Multivessel Coronary Artery Disease-Contrast Media, Hydration Status or Something Else? Nutrients. 2022;15(1).
  65. Santoro D, Gembillo G, Andò G. Glomerular Filtration Rate as a Predictor of Outcome in Acute
  66. Coronary Syndrome Complicated by Atrial Fibrillation. J Clin Med. 2020;9(5).
  67. Friedman T, Leviner DB, Chan V, Yanagawa B, Orbach A, Natour AEH, et al. High sensitivity
  68. troponin-I threshold to predict perioperative myocardial infarction. J Cardiothorac Surg. 2023;18(1):234.
  69. Chauin A. The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations
  70. Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease,
  71. Pulmonary Embolism, Renal Failure, Sepsis. Vasc Health Risk Manag. 2021;17:601-17.
  72. Stanton AA. Are We Sure We Know the Risk Factors for Cardiovascular Disease?∗. JACC. 2023;81(23):2255-7.
  73. B. Shahouzehi HF, Y. Masoumi -Ardakani. L-carnitine administration effects on AMPK, APPL1
  74. and PPARγ genes expression in the liver and serum adiponectin levels and HOMA-IR in type 2 diabetes rat
  75. model induced by ST Z and nicotinamide. Ukr Biochem J. 2020;92(2409-4943).
  76. Sawaguchi T, Nakajima T, Haruyama A, Hasegawa T, Shibasaki I, Nakajima T, et al. Association
  77. of serum leptin and adiponectin concentrations with echocardiographic parameters and
  78. pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery.
  79. PLoS One. 2019;14(11):e0225008.
  80. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al. Adiponectin protects
  81. against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11(10):1096-103.
  82. Chan P-C, Liao M-T, Hsieh P-S. The Dualistic Effect of COX-2-Mediated Signaling in Obesity
  83. and Insulin Resistance. International Journal of Molecular Sciences. 2019;20(13):3115.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)